Genetic testing for ovarian cancer may help inform treatment decisions for patients with advanced disease, particularly regarding PARP inhibitor use.
Melissa K. Frey, MD
Advertisement
Articles by Melissa K. Frey, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Mosunetuzumab Treatment Combo Yields Responses in High-Risk MCL
2
How To Discuss Death? A Conversation of Mortality in Cancer Care
3
Giredestrant Combo Significantly Boosts PFS in ER+ Advanced Breast Cancer
4
Dara-KRd Regimen Displays Prolonged PFS in Newly Diagnosed Multiple Myeloma
5
